trial · primary record
SRN-101
Recurrent High Grade Gliomas
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2030-01 |
| Primary endpoint | Evaluation of the safety and tolerability of SRN-101 in adult participants with recurrent high-grade glioma. |
| Registry ID | NCT07902037 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:55.819Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902037
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Srn-101 · compound